Phase 1 Xerostomia Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
Radiation-Induced Xerostomia and Hyposalivation
RiboX Therapeutics Ltd.42 enrolled4 locationsNCT06714253
Recruiting
Phase 1
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Xerostomia
University of Wisconsin, Madison36 enrolled1 locationNCT06392711
Recruiting
Phase 1
d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
Xerostomia
Stanford University40 enrolled1 locationNCT04392622
Recruiting
Phase 1Phase 2
A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
Radiation-induced Xerostomia
West China Hospital58 enrolled1 locationNCT07035626